OTCMKTS:ECTE Echo Therapeutics (ECTE) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ECTE Stock Alerts $0.0002 0.00 (0.00%) (As of 09/7/2021) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.00▼$0.28VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Echo Therapeutics alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Echo Therapeutics Stock (OTCMKTS:ECTE)Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.Read More ECTE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ECTE Stock News HeadlinesDecember 9, 2023 | bbc.co.ukWhat are echo chambers?December 3, 2023 | investing.comECTE/USD Synthetic Historical DataApril 25, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.October 18, 2023 | investing.comECTE Historical DataJuly 11, 2023 | cnet.comBest Smart Speakers for 2023: We Tested Alexa, Google, Apple and MoreJanuary 11, 2023 | usatoday.comIn echo of Jan. 6 attack in U.S., Brazilian protesters storm their Congress, high court and palaceNovember 28, 2022 | yahoo.comNow is the time to buy an Echo Dot smart speaker on Amazon — prices start at just $14.99, and the newest model is under $40!November 24, 2022 | yahoo.comEvery Single Echo Dot Black Friday Deal Happening Right NowApril 25, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.October 11, 2022 | cnet.comYou Should Buy the 4th-Gen Echo Dot This Prime Day, Not the New One. Here's WhyJune 1, 2022 | yahoo.comEverything we know about how to watch Marvel’s ‘Echo’ on Disney+August 9, 2021 | barrons.comEcho Therapeutics Inc.See More Headlines Receive ECTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2016Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolOTCMKTS:ECTE Previous SymbolNASDAQ:ECTE CUSIPN/A CIK1031927 Webwww.echotx.com Phone(732) 201-4194Fax215-717-4109Employees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesAlan Wayne SchoenbartChief Financial OfficerKey CompetitorsADM Tronics UnlimitedOTCMKTS:ADMTAksysOTCMKTS:AKSYGetinge AB (publ)OTCMKTS:GNGBYHeart TronicsOTCMKTS:HRTTIMRISOTCMKTS:IMRSQView All Competitors ECTE Stock Analysis - Frequently Asked Questions How have ECTE shares performed in 2024? Echo Therapeutics' stock was trading at $0.0002 at the start of the year. Since then, ECTE stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here. How were Echo Therapeutics' earnings last quarter? Echo Therapeutics, Inc. (OTCMKTS:ECTE) released its earnings results on Friday, August, 12th. The medical device company reported ($0.82) EPS for the quarter. During the same quarter in the previous year, the business earned ($0.97) earnings per share. What other stocks do shareholders of Echo Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC), DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), LadRx (CYTR), Glu Mobile (GLUU), InterCloud Systems (ICLD), NetApp (NTAP) and How do I buy shares of Echo Therapeutics? Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ECTE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Echo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
